Charlotte Haug, MD, PhD, MSc JAMA. 2009;302(7):795-796. When do physicians know enough about the beneficial effectsof a new medical intervention to start recommending or usingit? When is the available information about harmful adverseeffects sufficient to conclude that the risks outweigh the potentialbenefits? If in doubt, should physicians err on the side ofcaution or on the side […]
JAMA. 2009 Aug 19;302(7):750-7. Abstract CONTEXT: In June 2006, the Food and Drug Administration licensed the quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccine (qHPV) in the United States for use in females aged 9 to 26 years; the Advisory Committee on Immunization Practices then recommended qHPV for routine vaccination of […]
From Medscape Medical News September 23, 2009 (Düsseldorf, Germany) — Investigators have identified cases of autoimmune disorders after immunization with the quadrivalent vaccine Gardasil. The Merck product is designed to prevent infection with several types of human papillomavirus. Presenting here at the 25th Congress of the European Committee for Treatment and Research in Multiple […]
From Medscape Medical News October 28, 2009 (Baltimore, Maryland) — Investigators are reporting a case of motor neuron disease after immunization with the quadrivalent vaccine Gardasil. The Merck product is designed to prevent infection with several types of human papillomavirus. Presenting here at the 134th annual meeting of the American Neurological Association, researchers describe a […]
Found 21,022 events where Vaccine is HPV, HPV2, and HPV4. All HPV VACCINES COMBINED Found 89 events where Vaccine is HPV, HPV2, and HPV4 and Patient Died. View report here.